Portal hemodynamic effects of lenvatinib in patients with advanced hepatocellular carcinoma: A prospective cohort study.
Hisashi HidakaHaruki UojimaTakahide NakazawaXue ShaoYusuke HaraShuichiro IwasakiNaohisa WadaKosuke KubotaYoshiaki TanakaAkitaka ShibuyaYuhsaku KanohShigehiro KokubuWasaburo KoizumiPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2020)
Considering that this was a short-term study, because lenvatinib could be an agent that aggravates portal hypertension, it will be necessary to verify its clinical effects for portal hypertension in future studies.
Keyphrases